1 / 24

Food Allergy Update

Food Allergy Update. Thomas Flaim, M.D. Prevalence of Food Allergy. Prevalence rate is 6% in children < 3 years of age; 4% in adults Atopic children have higher prevalence Most common are milk (infants), egg (toddler), and peanut (school age)

Download Presentation

Food Allergy Update

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Food Allergy Update Thomas Flaim, M.D.

  2. Prevalence of Food Allergy • Prevalence rate is 6% in children < 3 years of age; 4% in adults • Atopic children have higher prevalence • Most common are milk (infants), egg (toddler), and peanut (school age) • 35% of children with moderate to severe atopic dermatitis have food allergy

  3. Epidemiology of Food Allergy • 30,000 food-induced anaphylactic reactions/year in U.S. • 2000 hospitalizations/year in U.S. • 200 deaths/year in U.S.

  4. Effects of Early Nutritional Interventions on the Development of Atopic Disease • No protective effect of a maternal exclusion diet during pregnancy • Modest decrease in risk of atopic dermatitis and milk allergy with exclusive breastfeeding for 4 months in high risk infants • Insufficient data for preventing and/or delaying food allergy with exclusive breastfeeding • For infants after 4-6 months of age, there are insufficient data to support a protective effect of any dietary intervention for the development of atopic disease Pediatrics 2008;121;183-191.

  5. Natural History of Food Allergy • Outgrown by age: • Milk – 20% (4 years); 40% (8 years); 60% (12 years); 80% (16 years) • Egg – 10% (4 years); 40% (8 years); 65% (12 years); 80% (16 years) • Peanut – 20% • Tree nuts – 10%

  6. Fatality due to Food Allergy • Peanut/nut most common cause • Milk responsible for 10% • Risk factors include: • Delayed use of Epinephrine • Asthma • Adolescent/young adult

  7. IgE-Mediated Food Hypersensitivity • Type I hypersensitivity reaction • Symptoms within minutes to 2 hours after ingestion • Skin prick testing • positive results - 50% tolerate foods • negative results – negative predictive accuracy of >95% • In vitro allergen-specific testing • similar to skin prick testing

  8. IgE-Mediated Food Hypersensitivity • Double-blind placebo-controlled food challenge (DBPCFC) is “gold standard” for establishing diagnosis • Conducted in clinic or hospital setting • May perform every 1-2 days

  9. Peanut Allergy • Prevalence of 1% • Rate has doubled in past decade • Severity of clinical reactions does not correlate with serum peanut-specific IgE results • Coallergy with legumes is 5% and tree nuts 25-50%

  10. Peanut Allergy • Labeling laws now require declaration of peanut proteins • “may contain peanut” and “made in a factory that processes peanut” • Casual contact through touch or inhalation generally not a problem

  11. Peanut Allergy • 20% will outgrow, must be confirmed with oral challenge • 8% have recurrence but these patients did not incorporate peanut into diet • 7% of younger siblings will have peanut allergy

  12. Peanut Allergy Treatment • Avoidance • Emergency epinephrine available • Anti-IgE therapy (1/2 to 9 peanuts tolerated) • Sublingual or oral immunotherapy • Chinese herbal medicine • Immunotherapy (plasmid, peptide etc)

  13. Milk Allergy • 2.5% of newborn infants experience hypersensitivity reactions <1 year of age • 60% are IgE-mediated; 50% then develop other food allergies • Most with non-IgE-mediated reactions ‘outgrow’ by 3 years of life • Coallergy – beef in 10% of patients

  14. Egg Allergy • 70% tolerate extensively heated egg in baked goods • 20% will develop peanut allergy

  15. Tree Nut Allergy • Most common: • Walnuts – 34% • Cashews – 20% • Almonds – 15% • Pecans – 9% • Pistachio – 7%

  16. Fish Allergy • Allergen more susceptible to manipulation eg. Canned tuna, salmon • Allergens can become aerosolized • allergy to multiple fishes is common

  17. Shellfish Allergy • Mollusks – snails, clams, oysters, scallops, squids, octopus, mussels • Crustacea – shrimp, lobsters, crabs, prawns, crawfish • Allergens can become aerosolized • Considerable cross-reactivity among crustacea

  18. Treatment • Injectable epinephrine available • <50 lbs- Epipen Jr. (.15 mg) SQ • >50 lbs – Epipen (.30 mg) SQ • Avoidance • Immunotherapy (SQ, sublingual and oral) under investigation • Omalizumab (anti-IgE) • Chinese herbal remedies

  19. Non-IgE-Mediated Food Hypersensitivity • Type IV – cell-mediated • Eosinophilic esophagitis and gastroenteritis • Atopic dermatitis • Celiac disease

  20. Non-IgE-Mediated Food Hypersensitivity • Food protein-induced enterocolitis syndrome • Food protein-induced colitis • Dietary protein-induced enteropathy • Symptoms include vomiting, diarrhea

  21. Non-IgE-Mediated Food Hypersensitivity • Potential complications include bloody diarrhea, FTT, malabsorption, dehydration • Etiologic agents – milk and/or soy based formula, breast milk • Treatment is avoidance and use of elemental formula • Resolution in majority of infants by 2 years of age

  22. Class 2 Allergenic Proteins • Consequence of an allergic sensitization to inhalant allergens • “Latex-fruit” allergy (banana, avocado, chestnut, kiwi, fig) • Oral Allergy Syndrome

  23. Oral Allergy Syndrome • Symptoms confined to oropharynx and rarely involve other target organs • Cooked foods tolerated • Birch pollen • Apple, pear, peach, cherry, apricot, plum, carrot, celery, potato, hazelnut • Ragweed • melons

  24. Conclusions • Make a correct diagnosis (food allergy cripples)! • Treatment is avoidance and availability of injectable epinephrine although we should have therapy in next 10-20 years

More Related